Refine
Year of publication
Document Type
- Article (44)
- Preprint (4)
- Contribution to a Periodical (3)
- Book (1)
- Conference Proceeding (1)
Language
- English (48)
- German (4)
- Multiple languages (1)
Has Fulltext
- yes (53)
Is part of the Bibliography
- no (53)
Keywords
- SARS-CoV-2 (4)
- Angiogenesis (2)
- COVID-19 (2)
- COVID19-NMR (2)
- CRM (2)
- Everolimus (2)
- Kidney transplantation (2)
- Lipidomics (2)
- Mechanisms of disease (2)
- Metabolomics (2)
- Pediatric (2)
- Solution NMR spectroscopy (2)
- Wound healing (2)
- aging (2)
- portal hypertension (2)
- stroke (2)
- 5'-UTR (1)
- 5_SL4 (1)
- 5′-UTR (1)
- ACLF (1)
- ADHD (1)
- Abductor pollicis longus (1)
- Antibody-mediated rejection (1)
- Arthroplasty (1)
- Autosomal recessive cutis laxa type 1C (1)
- Biomarker Discovery Study (1)
- Biopsy (1)
- Brain tumor (1)
- COVID (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Carnivores (1)
- Cirrhosis (1)
- Colorectal cancer (1)
- Consensus document (1)
- Cytokines (1)
- Diabetes (1)
- Divergence time estimate (1)
- ECM (1)
- EET (1)
- EWSR1 (1)
- Ears (1)
- Elastogenesis (1)
- Emergency room (1)
- Endothelial progenitor cells (1)
- Epithelialization (1)
- Exercise training (1)
- Extracellular matrix (1)
- FOXO3a (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Gene fusion (1)
- Generalist (1)
- Hashimoto’s thyroiditis (1)
- Heart failure (1)
- Implantable cardioverter-defibrillator (1)
- Inflammation (1)
- Injury (1)
- Interposition (1)
- Ischemia (1)
- K3EDTA plasma sampling (1)
- LBP (1)
- LC-MS-Based Clinical Research (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Liver diseases (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- MN1 (1)
- Metalloproteases (1)
- Molecular medicine (1)
- NMR spectroscopy (1)
- Neuroepithelial (1)
- Neurooncology (1)
- Oncogenes (1)
- PARK2 (1)
- PATZ1 (1)
- PDE‐5‐inhibitor (1)
- PTDM (1)
- Pacemaker (1)
- Phylogeography (1)
- Physical activity (1)
- Platelets (1)
- Portal veins (1)
- Post-transplant (1)
- Pre-analytics (1)
- Prevention (1)
- Prostaglandin (1)
- RNA (1)
- RNA genome (1)
- RNA-binding proteins (1)
- Randomized (1)
- RegJoint™ (1)
- SL1 (1)
- SPSS (1)
- Sampling protocol (1)
- Suspension (1)
- TOR inhibitor (1)
- Thrombosis (1)
- Thromboxane (1)
- Thumb carpometacarpal joint osteoarthritis (1)
- Trauma (1)
- Vasculogenesis (1)
- Veins (1)
- Vulpes (1)
- X-ray crystallography (1)
- accessory proteins (1)
- accident (1)
- acute decompensation (1)
- acute-on-chronic liver failure (1)
- bioactivity testing (1)
- cancer (1)
- cell-free protein synthesis (1)
- chronic low back pain (1)
- cirrhosis (1)
- computed tomography (1)
- diabetes (1)
- differentiated thyroid carcinoma (1)
- diffusion model (1)
- disease modelling (1)
- easyPACId (1)
- emergency care (1)
- erectile dysfunction (1)
- exercise (1)
- glycobiology (1)
- glycoconjugate (1)
- hepatic encephalopathy (1)
- hiPSC (1)
- infectious disease (1)
- inflammation (1)
- inflammatory reaction (1)
- injury (1)
- intrinsically disordered region (1)
- liver (1)
- lockdown (1)
- lumbago (1)
- lumbalgia (1)
- mTOR inhibitor (1)
- meta-analysis (1)
- metabolic syndromes (1)
- mitochondria (1)
- molecular modeling (1)
- motor control exercise (1)
- mtDNA control region (1)
- natural products (1)
- neovascularization (1)
- neurodegeneration (1)
- neutralizing antibodies (1)
- nonspecific (1)
- nonstructural proteins (1)
- non‐selective beta‐blocker (1)
- paper-based assessment (1)
- pediatric intensive care (1)
- portosystemic shunt (1)
- processing speed (1)
- proliferation (1)
- proteobacteria (1)
- retrovirus (1)
- sensorimotor (1)
- sialic acid (1)
- simplified production (1)
- simulation (1)
- simulation training (1)
- sirtuin1 (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- stabilization (1)
- structural proteins (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- training (1)
- trauma (1)
- unspecific low back pain (1)
- variants of concern (1)
- vitamin D (1)
- vitamin D receptor (1)
- wound repair (1)
Institute
- Medizin (32)
- Biochemie, Chemie und Pharmazie (7)
- Biowissenschaften (7)
- Geowissenschaften (3)
- Präsidium (3)
- Senckenbergische Naturforschende Gesellschaft (2)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (2)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (1)
Siglec-1 (sialoadhesin, CD169) is a surface receptor on human cells that mediates trans-enhancement of HIV-1 infection through recognition of sialic acid moieties in virus membrane gangliosides. Here, we demonstrate that mouse Siglec-1, expressed on the surface of primary macrophages in an interferon-α-responsive manner, captures murine leukemia virus (MLV) particles and mediates their transfer to proliferating lymphocytes. The MLV infection of primary B-cells was markedly more efficient than that of primary T-cells. The major structural protein of MLV particles, Gag, frequently co-localized with Siglec-1, and trans-infection, primarily of surface-bound MLV particles, efficiently occurred. To explore the role of sialic acid for MLV trans-infection at a submolecular level, we analyzed the potential of six sialic acid precursor analogs to modulate the sialylated ganglioside-dependent interaction of MLV particles with Siglec-1. Biosynthetically engineered sialic acids were detected in both the glycolipid and glycoprotein fractions of MLV producer cells. MLV released from cells carrying N-acyl-modified sialic acids displayed strikingly different capacities for Siglec-1-mediated capture and trans-infection; N-butanoyl, N-isobutanoyl, N-glycolyl, or N-pentanoyl side chain modifications resulted in up to 92 and 80% reduction of virus particle capture and trans-infection, respectively, whereas N-propanoyl or N-cyclopropylcarbamyl side chains had no effect. In agreement with these functional analyses, molecular modeling indicated reduced binding affinities for non-functional N-acyl modifications. Thus, Siglec-1 is a key receptor for macrophage/lymphocyte trans-infection of surface-bound virions, and the N-acyl side chain of sialic acid is a critical determinant for the Siglec-1/MLV interaction.
The project focuses on the efficiency of combined technologies to reduce the release of micropollutants and bacteria into surface waters via sewage treatment plants of different size and via stormwater overflow basins of different types. As a model river in a highly populated catchment area, the river Schussen and, as a control, the river Argen, two tributaries of Lake Constance, Southern Germany, are under investigation in this project. The efficiency of the different cleaning technologies is monitored by a wide range of exposure and effect analyses including chemical and microbiological techniques as well as effect studies ranging from molecules to communities.
Background: Protective effects of vitamin D have been reported in autoimmune and malignant thyroid diseases, though little is known about the underlying mechanism. Sirtuin 1 histon deacethylase (SIRT1) links the vitamin D pathway with regulation of transcription factor FOXO3a, a key player in cell cycle regulation and apoptosis. Aim of the present study was to investigate common single nucleotide polymorphisms (SNP's) in FOXO3a gene in respect to thyroid diseases, as well as to evaluate the hypothesis of Sirtuin1-FOXO3a interaction being a mediator of anti-proliferative vitamin D effects.
Methods: The SNP's FOXO3a rs4946936/rs4945816/rs9400239 were genotyped in 257 patients with differentiated thyroid carcinoma (DTC), 139 patients with Hashimoto thyroiditis (HT) and 463 healthy controls (HC). Moreover, T-helper cells of HC and papillary thyroid cancer cell line BCPAP were incubated with 1,25(OH)2D3 and/or SIRT1 inhibitor Ex-527 in order to elucidate SIRT1- dependent vitamin D effects on cell proliferation and FOXO3a gene expression in vitro.
Results: Patients with DTC tended to carry more often allele C in FOXO3a rs4946936 in comparison to HC (pcorrected = pc = 0.08). FOXO3a rs9400239T and rs4945816C was more frequent in HT in comparison to HC (pc = 0.02 and pc = 0.01, respectively). In both DTC and HT, we could not find a correlation of FOXO3a SNP's with vitamin D status. However, on in vitro level, 1,25(OH)2D3 showed an anti-proliferative effect in both T-helper cells and BCPAP, that was blocked by SIRT1 inhibition (T-helper cells: p = 0.0059, BCPAP: p = 0.04) and accompanied by elevated FOXO3a gene expression in T-helper cells (p = 0.05).
Conclusions: FOXO3a rs9400239T and rs4945816C may constitute risk factors for HT, independent of the vitamin D status.This indicates the implication of FOXO3a in pathogenesis of autoimmune thyroid diseases. The dependency of anti-proliferative vitamin D effects on SIRT1 activity further suggests a key role of vitamin D-SIRT1-FOXO3a axis for protective vitamin D effects.